T-Cell Transfer Therapy Targeting Mutant KRAS.

@article{Rosenberg2017TCellTT,
  title={T-Cell Transfer Therapy Targeting Mutant KRAS.},
  author={Steven A Rosenberg and Eric Tran and Paul F. Robbins},
  journal={The New England journal of medicine},
  year={2017},
  volume={376 7},
  pages={e11}
}
To the Editor: Tran et al. (Dec. 8 issue)1 describe a remarkable case of a patient with metastatic colorectal cancer treated with autologous T cells specific for mutant KRAS G12D and restricted to the major histocompatibility complex class I allele HLA-C*08:02. The authors hypothesize that in the United States alone, thousands of patients per year may be eligible for T-cell–based immunotherapy targeting KRAS G12D. To estimate how common this opportunity may be, we identified 151 patients with… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.

Similar Papers

Loading similar papers…